• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者年龄和狭窄部位对Wingspan支架内再狭窄的影响。

Influence of patient age and stenosis location on wingspan in-stent restenosis.

作者信息

Turk A S, Levy E I, Albuquerque F C, Pride G L, Woo H, Welch B G, Niemann D B, Purdy P D, Aagaard-Kienitz B, Rasmussen P A, Hopkins L N, Masaryk T J, McDougall C G, Fiorella D

机构信息

Departments of Radiology and Neurosurgery, Medical University of South Carolina, Charleston, SC, USA.

出版信息

AJNR Am J Neuroradiol. 2008 Jan;29(1):23-7. doi: 10.3174/ajnr.A0869. Epub 2007 Nov 7.

DOI:10.3174/ajnr.A0869
PMID:17989366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8119103/
Abstract

BACKGROUND AND PURPOSE

Wingspan is a self-expanding, microcatheter-delivered microstent specifically designed for the treatment of symptomatic intracranial atherosclerotic disease. Our aim was to discuss the effect of patient age and lesion location on in-stent restenosis (ISR) rates after percutaneous transluminal angioplasty and stenting (PTAS) with the Wingspan system.

MATERIALS AND METHODS

Clinical and angiographic follow-up results were recorded for all patients from 5 participating institutions. ISR was defined as >50% stenosis within or immediately adjacent (within 5 mm) to the implanted stent and >20% absolute luminal loss. For the present analysis, patients were stratified into younger (</=55 years) and older (>55 years) age groups.

RESULTS

ISR occurred at a rate of 45.2% (14/31) in the younger group and 24.2% (15/62) in the older group (odds ratio, 2.6; 95% confidence interval, 1.03-6.5). In the younger group, ISR occurred after treatment of 13/26 (50%) anterior circulation lesions versus only 1/5 (20%) posterior circulation lesions. In the older group, ISR occurred in 9/29 (31.0%) anterior circulation lesions and 6/33 (18.2%) posterior circulation lesions. In young patients, internal carotid artery lesions (10/17 treated, 58.8%), especially those involving the supraclinoid segment (8/9, 88.9%), were very prone to ISR. When patients of all ages were considered, supraclinoid segment lesions had much higher rates of both ISR (66.6% versus 24.4%) and symptomatic ISR (40% versus 3.9%) in comparison with all other locations.

CONCLUSION

Post-Wingspan ISR is more common in younger patients. This increased risk can be accounted for by a high prevalence of anterior circulation lesions in this population, specifically those affecting the supraclinoid segment, which are much more prone to ISR and symptomatic ISR than all other lesions.

摘要

背景与目的

Wingspan是一种可通过微导管输送的自膨胀微支架,专门设计用于治疗有症状的颅内动脉粥样硬化疾病。我们的目的是探讨患者年龄和病变部位对采用Wingspan系统进行经皮腔内血管成形术和支架置入术(PTAS)后支架内再狭窄(ISR)发生率的影响。

材料与方法

记录了来自5个参与机构的所有患者的临床和血管造影随访结果。ISR定义为植入支架内或紧邻支架(5mm内)出现>50%的狭窄以及管腔绝对损失>20%。在本次分析中,患者被分为较年轻(≤55岁)和较年长(>55岁)年龄组。

结果

较年轻组的ISR发生率为45.2%(14/31),较年长组为24.2%(15/62)(优势比,2.6;95%置信区间,1.03 - 6.5)。在较年轻组中,13/26(50%)的前循环病变治疗后发生ISR,而后循环病变仅1/5(20%)发生ISR。在较年长组中,9/29(31.0%)的前循环病变和6/33(18.2%)的后循环病变发生ISR。在年轻患者中,颈内动脉病变(10/17接受治疗,58.8%),尤其是累及床突上段的病变(8/9,88.9%),非常容易发生ISR。当考虑所有年龄段的患者时,与所有其他部位相比,床突上段病变的ISR(66.6%对24.4%)和有症状ISR(40%对3.9%)发生率都高得多。

结论

Wingspan术后ISR在较年轻患者中更常见。该人群中前循环病变的高患病率可解释这种增加的风险,特别是那些影响床突上段的病变,其比所有其他病变更容易发生ISR和有症状ISR。

相似文献

1
Influence of patient age and stenosis location on wingspan in-stent restenosis.患者年龄和狭窄部位对Wingspan支架内再狭窄的影响。
AJNR Am J Neuroradiol. 2008 Jan;29(1):23-7. doi: 10.3174/ajnr.A0869. Epub 2007 Nov 7.
2
Angiographic patterns of Wingspan in-stent restenosis.Wingspan支架内再狭窄的血管造影模式。
Neurosurgery. 2008 Jul;63(1):23-7; discussion 27-8. doi: 10.1227/01.NEU.0000335067.53190.A2.
3
How do we spin wingspan?我们如何旋转翼展?
AJNR Am J Neuroradiol. 2008 Jan;29(1):28-9. doi: 10.3174/ajnr.A0883. Epub 2007 Nov 26.
4
Response to the commentary "how do we spin wingspan?".对评论文章“我们如何推广Wingspan(产品名)?”的回应
AJNR Am J Neuroradiol. 2008 Sep;29(8):e67-8; author reply e70. doi: 10.3174/ajnr.A1081. Epub 2008 Apr 3.
5
Target lesion revascularization after wingspan: assessment of safety and durability.Wingspan术后靶病变血管重建:安全性和持久性评估
Stroke. 2009 Jan;40(1):106-10. doi: 10.1161/STROKEAHA.108.525774. Epub 2008 Oct 16.
6
Re: Turk et al and the "how do we spin wingspan?" commentary.关于:图尔克等人以及“我们如何解读翼展?”的评论。
AJNR Am J Neuroradiol. 2008 Sep;29(8):e69; author reply e70. doi: 10.3174/ajnr.A1084. Epub 2008 Apr 3.
7
Intracranial stent restenosis diagnosed on routine duplex follow-up investigation.在常规双功超声随访检查中诊断出颅内支架再狭窄。
AJNR Am J Neuroradiol. 2008 Sep;29(8):e65; author reply e66. doi: 10.3174/ajnr.A1080. Epub 2008 Jul 18.
8
[Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis].[症状性颅内动脉狭窄治疗中翼展支架内再狭窄的预测因素]
Zhonghua Yi Xue Za Zhi. 2011 May 24;91(19):1303-7.
9
Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.翼展支架内再狭窄和血栓形成:发生率、临床表现及处理
Neurosurgery. 2007 Sep;61(3):644-50; discussion 650-1. doi: 10.1227/01.NEU.0000290914.24976.83.
10
Wingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosis.Wingspan 支架治疗颅内动脉粥样硬化性狭窄:支架内再狭窄的临床转归和危险因素。
Neurosurgery. 2013 Apr;72(4):596-604; discussion 604. doi: 10.1227/NEU.0b013e3182846e09.

引用本文的文献

1
Next-generation Onyx DES for elective intracranial atherosclerosis: A meta-analysis.用于择期颅内动脉粥样硬化的新一代奥尼克斯药物洗脱支架:一项荟萃分析。
Interv Neuroradiol. 2025 Jul 28:15910199251361312. doi: 10.1177/15910199251361312.
2
Risk factors for in-stent stenosis after flow-diverter implantation for intracranial aneurysm: a single center analysis of 161 consecutive patients.颅内动脉瘤血流导向装置植入术后支架内狭窄的危险因素:161例连续患者的单中心分析
Acta Neurochir (Wien). 2025 Jul 17;167(1):194. doi: 10.1007/s00701-025-06597-2.
3
Development and validation of a nomogram for in-stent restenosis within 2 years in patients after iliac or femoral artery stent placement.髂动脉或股动脉支架置入术后患者2年内支架内再狭窄预测模型的建立与验证
BMC Surg. 2025 May 21;25(1):221. doi: 10.1186/s12893-025-02955-0.
4
Higher Time to Peak after Stent Implantation in Symptomatic High-Grade Intracranial Atherosclerotic Stenosis is Related to In-Stent Restenosis.症状性重度颅内动脉粥样硬化狭窄患者支架植入术后达到峰值时间延长与支架内再狭窄有关。
Transl Stroke Res. 2025 Mar 22. doi: 10.1007/s12975-025-01346-0.
5
A case report of high cervical spinal infarction after stenting with severe stenosis at the beginning of left vertebral artery.左侧椎动脉起始部重度狭窄支架置入后发生高位颈髓梗死 1 例报告
Medicine (Baltimore). 2024 Aug 9;103(32):e39161. doi: 10.1097/MD.0000000000039161.
6
Comprehensive Analysis of Post-Pipeline Endothelialization and Remodeling.综合分析管道内皮化和重塑。
AJNR Am J Neuroradiol. 2024 Jul 8;45(7):893-898. doi: 10.3174/ajnr.A8228.
7
A bibliometric analysis of the 100 most-cited clinical articles in the research of intracranial artery stenosis and intracranial atherosclerosis.颅内动脉狭窄与颅内动脉粥样硬化研究中被引用次数最多的100篇临床文章的文献计量学分析
Surg Neurol Int. 2024 Mar 8;15:74. doi: 10.25259/SNI_1030_2023. eCollection 2024.
8
Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors.严重症状性颅内动脉粥样硬化狭窄血管内治疗的并发症和长期支架内再狭窄及相关危险因素。
Medicine (Baltimore). 2023 Sep 22;102(38):e34697. doi: 10.1097/MD.0000000000034697.
9
Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis.识别有症状颅内动脉粥样硬化性狭窄患者支架内再狭窄的危险因素:一项系统评价和荟萃分析。
Front Neurol. 2023 Jul 14;14:1170110. doi: 10.3389/fneur.2023.1170110. eCollection 2023.
10
Machine learning to predict in-stent stenosis after Pipeline embolization device placement.机器学习用于预测Pipeline栓塞装置置入术后的支架内狭窄
Front Neurol. 2022 Sep 6;13:912984. doi: 10.3389/fneur.2022.912984. eCollection 2022.

本文引用的文献

1
Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.翼展支架内再狭窄和血栓形成:发生率、临床表现及处理
Neurosurgery. 2007 Sep;61(3):644-50; discussion 650-1. doi: 10.1227/01.NEU.0000290914.24976.83.
2
A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.一项关于使用球囊扩张冠状动脉支架治疗有症状的椎基底动脉颅内动脉粥样硬化疾病的7年经验。
Neurosurgery. 2007 Aug;61(2):236-42; discussion 242-3. doi: 10.1227/01.NEU.0000255521.42579.31.
3
Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses.紫杉醇洗脱支架治疗颅内后循环狭窄的中期结果
J Neurosurg. 2007 Feb;106(2):222-5. doi: 10.3171/jns.2007.106.2.222.
4
US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.美国使用Wingspan支架系统治疗颅内动脉粥样硬化疾病的多中心经验:围手术期结果
Stroke. 2007 Mar;38(3):881-7. doi: 10.1161/01.STR.0000257963.65728.e8. Epub 2007 Feb 8.
5
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.药物洗脱支架的晚期血栓形成:随机临床试验的荟萃分析
Am J Med. 2006 Dec;119(12):1056-61. doi: 10.1016/j.amjmed.2006.01.023.
6
Intracranial angioplasty and stenting: long-term results from a single center.颅内血管成形术和支架置入术:单中心长期结果
AJNR Am J Neuroradiol. 2006 Oct;27(9):1882-92.
7
Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.药物洗脱支架在颅内和颅外循环中置入的安全性、可行性及短期随访
Stroke. 2006 Oct;37(10):2562-6. doi: 10.1161/01.STR.0000242481.38262.7b. Epub 2006 Sep 7.
8
Angioplasty for symptomatic intracranial stenosis: clinical outcome.症状性颅内狭窄的血管成形术:临床结果
Stroke. 2006 Apr;37(4):1016-20. doi: 10.1161/01.STR.0000206142.03677.c2. Epub 2006 Feb 23.
9
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.华法林与阿司匹林治疗有症状颅内动脉狭窄的比较。
N Engl J Med. 2005 Mar 31;352(13):1305-16. doi: 10.1056/NEJMoa043033.
10
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up.无症状性动脉粥样硬化狭窄的颅内血管成形术(无支架置入):长期随访
AJNR Am J Neuroradiol. 2005 Mar;26(3):525-30.